Growth hormone binding protein (GHBP) is complexed to a substantial fraction of circulating GH. In humans, rabbits, and some other species, GHBP derives by proteolytic shedding of GH receptor (GHR) extracellular domain. In cell culture studies, stimuli such as phorbol ester, platelet-derived growth factor, or serum induce GHR proteolysis, which concomitantly yields shed GHBP in cell supernatants and a cellassociated cytoplasmic domain-containing GHR remnant. This process is sensitive to metalloprotease inhibition, and genetic reconstitution studies identify tumor necrosis factor-α converting enzyme (TACE/ADAM-17), a transmembrane metalloprotease, as a GHR sheddase. Stimuli that induce GHR proteolysis render cells less responsive to GH, but the mechanism(s) of this desensitization is not yet understood. In this study, we mapped the rabbit (rb) GHR cleavage site. We adenovirally expressed a C-terminally epitope-tagged rbGHR lacking most of its cytoplasmic domain, purified the remnant protein induced by the phorbol ester, PMA, and derived the cleavage site by N-terminal sequencing of the purified remnant. The N-terminal sequence, F 239 TCEEDFR 246 , matched perfectly the rbGHR and suggests that cleavage occurs eight residues from the membrane in the proximal extracellular domain stem region. Deletion and alanine substitution mutagenesis indicated that, similar to other TACE substrates, the spacing of residues in this region, more than their identity, influences the GHR's cleavage susceptibility. Further, we determined that PMA pretreatment desensitized a cleavagesensitive GHR mutant, but not a cleavage-insensitive mutant, to GH-induced JAK2 activation. These results suggest that inducible GHR proteolysis can regulate GH signaling.
INTRODUCTION
Growth hormone (GH) is an anterior pituitary-derived hormone that exerts somatogenic and metabolic effects by interacting with the GH receptor (GHR) on target cells (1) . The GH-bound dimerized GHR causes engagement of intracellular signaling cascades by activating the receptor-associated cytoplasmic tyrosine kinase, JAK2 (2) .
Activation of pathways including the signal transducer and activator of transcription (STAT) 5, MAP kinase, and phosphatidylinositol-3 kinase pathways, results in expression of insulin-like growth factor-1 and other target genes that contribute to GH's effects (3, 4) .
A substantial fraction (roughly one-half in humans) of circulating GH is bound to a high-affinity GH binding protein (GHBP), which corresponds to the extracellular ligand-binding domain of the GHR (5, 6) . Depending on species, GHBP is generated by two distinct mechanisms. In rodents, alternative splicing of the GHR mRNA yields a secreted form that includes the extracellular domain (7) (8) (9) . In humans, rabbits, and other species, GHBP is derived by proteolysis of the GHR (reviewed in 10). This yields a soluble receptor extracellular domain in a process termed proteolytic GHBP shedding.
An obligatory byproduct of proteolytic GHBP shedding is the so-called GHR "remnant", a cytoplasmic domain-containing cell-associated fragment of the receptor that remains after the extracellular domain is shed (11) (12) (13) .
We have previously shown in cell culture model systems that GHR proteolysis (receptor loss, remnant accumulation, and variable degrees of GHBP shedding) can be induced by several stimuli: 1) pharmacologic activation of protein kinase C by the phorbol ester, PMA; 2) treatment with platelet-derived growth factor (PDGF); or 3) treatment of serum-starved cells with serum (11) (12) (13) (14) . In each case, the inducible proteolysis is blocked by a metalloprotease inhibitor and genetic reconstitution studies suggest that tumor necrosis factor-α converting enzyme (TACE, also known as ADAM-17 (15, 16) ) can catalyze the processing (14) . In cells expressing either murine or rabbit (rb) GHRs, receptor proteolysis is accompanied by a decrease in the ability of subsequent stimulation with GH to elicit JAK2 activation, suggesting that metalloprotease-mediated heterologous desensitization may be a mechanism that impacts cellular responsiveness to GH (12) . Conversely, prior treatment with GH, but not with a GH antagonist, renders cells resistant to inducible GHR proteolysis (13) . This suggests that GH-induced receptor dimerization or a GH-induced conformational change in the receptor's extracellular dimerization domain and/or stem region may impede access to the cleaving enzyme.
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In this study, we examined GHR extracellular domain determinants for metalloprotease-mediated proteolysis.
Using adenoviral infection to accomplish abundant receptor expression, we identified a cleavage site in the rbGHR juxtamembrane region of the extracellular domain. We tested the importance of the identity of this site in allowing receptor proteolysis to occur by performing mutagenesis experiments. Finally, by comparing cleavage-sensitive vs. cleavage-resistant GHR mutants, we tested the effect of inducible receptor proteolysis on GH-induced signaling. 
MATERIALS AND METHODS

Materials
Cells, cell culture, transfection, and adenoviral infection
HEK-293 cells (a gift of Dr. C. Wu, University of Pittsburgh) cells were maintained in DMEM (low glucose) (Cellgro, Inc.) supplemented with 7 % fetal bovine serum (Biofluids, Rockville, MD) and 50 µg/ml gentamicin sulfate, 100U/ml penicillin, and 100 µg/ml streptomycin (all Biofluids). Transient transfection was achieved by introducing pCDNA 3.1-driven plasmids encoding GHR mutants (3 µg per transfection; see below for construction) with or without murine JAK2 (1 µg per transfection), as indicated, using Lipofectamine Plus (InVitrogen) according to the manufacturer's instructions. Adenoviral infection of HEK-293 cells was accomplished using methods previously reported (18) .
Plasmid construction
The rbGHR cDNA was a kind gift of Dr. W. Wood, Genentech, Inc.
Construction of the cDNA encoding rbGHR del 297-406 has been described (19, 20) . This mutant (referred to herein as "wild-type" or WT) has intact extracellular and transmembrane domains, but lacks residues 297-406 in the cytoplasmic domain (the fullby guest on January 1, 2018
http://www.jbc.org/ Downloaded from length rbGHR has 620 residues). Thus, the Box 1 region in the proximal cytoplasmic domain is intact, as is the distal two-thirds of the cytoplasmic domain, which contains known GHR tyrosine phosphorylation sites, but the major internalization motif is absent. This GHR mutant retains the ability to respond to GH by allowing tyrosine phosphorylation of itself and JAK2 (see Figure 7 ) and STAT5 (data not shown cDNAs expression vectors encoding the rbGHR cleavage region mutants, rbGHR-∆237-239, rbGHR-∆240-242, rbGHR-∆242-244, rbGHR-237-239AAA, rbGHR-240-242AAA, and rbGHR-242-244AAA, were each constructed using the ExSite (Stratagene) PCR-based site-directed mutagenesis method and the pCDNA3.1-rbGHR del 297-406 as the template. Sequences for the mutagenic oligonucleotides are available upon request. The deletion (∆) mutations removed in-frame the three contiguous amino acids indicated (numbering as in 5), while the alanine replacement mutations (AAA) changed the indicated residues to alanine. The entire protein coding sequence of each selected mutant cDNA was subjected to dideoxy DNA sequencing (UAB core facility), which verified the presence of the desired mutations and the absence of unwanted mutations.
Generation of recombinant adenoviruses
The methods for generating the adenovirally-expressed version of rbGHR del 297- The rabbit polyclonal antisera, anti-GHR cyt-AL47 , raised against a bacterially-expressed Nterminally-His-tagged fusion protein incorporating human GHR residues 271-620 (the entire cytoplasmic domain (5)), has been previously described (13) . Anti-GHR cyt-mAb is a mouse monoclonal antibody directed against a bacterially-expressed GST fusion protein incorporating human GHR residues 271-620 and has been previously described (20) .
Anti-JAK2 AL33 (directed at residues 746-1129 of murine JAK2) polyclonal serum has been described (23) .
Cell stimulation, protein extraction, immunoprecipitation, deglycosylation, electrophoresis, and immunoblotting and PMA (at 1 µg/ml) treatment protocols have been described (11) (12) (13) (14) 20, 24 Resolution of proteins by SDS-PAGE, Western transfer of proteins, and blocking of Hybond-ECL (Amersham, Inc.) with 2% BSA were performed as previously described (11) (12) (13) (14) . 
GHBP assay
GHBP activity was measured in conditioned media by a standard GH binding assay, as previously reported (11, 12, 28 
Densitometric analysis
Densitometric quantitation of ECL immunoblots was performed using a video camera and the Image 1. 
RESULTS
Adenovirally-expressed C-terminal epitope-tagged rbGHR cytoplasmic domain mutants undergo inducible proteolytic GHBP shedding in HEK-293 cells.
To better characterize GHR structural determinants for proteolytic shedding and map the cleavage site, we sought to develop a transient expression system that would ensure high GHR levels, but maintain the characteristics of the system we previously defined. In prior work, we characterized a rbGHR mutant that has an in-frame deletion of residues 297-406 in the cytoplasmic domain. rbGHR del 297-406 , which lacks the internalization and UbE motif (29, 30) , is highly expressed at the cell surface, binds GH normally, couples to GH-induced JAK2 activation, and, when stably-expressed in CHO cells, undergoes inducible metalloprotease-mediated, GH-inhibitable proteolysis and GHBP shedding (13, 19) . Infection of cells with replication-defective adenoviral vectors is an increasingly common method of achieving high-level eukaryotic protein expression.
We first tested whether rbGHR del 297-406 could be expressed adenovirally in human HEK-293 cells and, if so, would behave similarly regarding proteolytic shedding in this system as in those we previously studied.
We used the pAdlox system to prepare infectious adenoviral particles encoding a C-terminally His-tagged rbGHR del 297-406 , as in the Methods section. Infection of HEK-293 cells was efficient, with greater than 80% of cells exhibiting infection when GFP signal was detected by microscopy (data not shown). As seen in Figure 1 , immunoblotting with anti-GHR cyt-AL47 , which recognizes epitopes in the GHR cytoplasmic domain (13) , detected the receptor in unfractionated detergent extracts of the infected HEK-293 cells (lane 1). As we previously observed (13, 19) , this receptor mutant, like the wild-type rbGHR, appears as a mixture of indistinct and sharp bands which collectively migrate at roughly 75-100 kD, consistent with its glycosylation (more below). A more rapidly migrating and more distinct form was also detected by anti- suggest that both basal and inducible receptor proteolysis were occurring in this adenoviral system in a fashion qualitatively similar to our previous observations in other systems (11) (12) (13) . This was further supported by our ability to measure PMA-induced shedding of ample GHBP into the medium of these cells and inhibition of this shedding by IC3 ( Figure 1B ).
It is known that a naturally-occurring GHR splice variant lacking nearly the entire cytoplasmic domain generates substantial amounts of proteolytically shed GHBP (31, 32) .
For remnant purification, we designed and adenovirally expressed a rbGHR mutant, PMA-induced, IC3-inhibitable GHBP shedding into the cell supernatant was also readily detected ( Figure 2B ). In addition, pretreatment of the cells with GH prior to acute PMA exposure blunted the PMA-induced appearance of the remnant ( Figure 1C ), indicating that this property of the proteolytic shedding system that we have previously documented (13) was also intact in this system.
N-terminal sequencing of the purified GHR remnant.
These results suggested a strategy for identification of the inducible, metalloprotease-mediated GHR cleavage site utilizing adenoviral infection to express putative purified remnant in the Coomassie stained material. This band was excised and the protein was eluted and subjected to N-terminal sequencing by Edman degradation.
As seen in Figure 3B , the resulting amino acid sequence was FTCEEDFR, matching perfectly the known rbGHR extracellular domain sequence F 239 TCEEDFR 246 . This clearly confirmed that we indeed purified the intended protein and strongly suggested that the cleavage occurs between P 238 and F 239 in the extracellular juxtamembrane region of the receptor, with F 239 being eight residues N-terminal to the first transmembrane domain residue (5) . Of note, this is a region of highly conserved amino acid sequence between the rabbit and human GHRs ( Figure 3B ). It is also a region of the GHR extracellular domain about which little is known of the structure; the bacteriallyexpressed hGHR extracellular domain previously studied crystallographically encoded only residues 1-238 (33).
Proteolytic susceptibility of rbGHR cleavage region mutants.
There is no clear consensus sequence for cleavage among the various TACE substrates (34) . While the determinants for proteolysis are not known in all cases, the distance of the site of cleavage from the membrane or the position of the cleavage site relative to globular extracellular domain regions have been suggested as important determinants (35) . Given our remnant N-terminal sequencing results, we sought to determine the degree to which the receptor's susceptibility to proteolysis depended on the intactness of the site we identified. In these experiments, we used the rbGHR del 297-406 characterized in Figure 1 in HEK-293 cells and in our previous work in other cells (13, 19, 20) . For simplicity, this is referred to as the "wild-type" (WT) receptor for the remainder of this study because it contains the normal rbGHR sequence in the extracellular and transmembrane domains. In the framework of this receptor, we prepared cDNAs encoding mutations in the extracellular domain region encompassing and near to the cleavage site. (These mutants are referred to by the nature of the extracellular domain mutations, without reference to the in-frame cytoplasmic domain deletion that they all share.) The mutants (diagrammed in Figure 4 ) were designed to test whether the identity of the residues in the extracellular domain stem region vs. the length of this region was most critical for susceptibility to receptor proteolysis. Three stem region in-frame internally deleted mutants were engineered that each lack three contiguous residues (rbGHR-∆237-239, rbGHR-∆240-242, and rbGHR-∆242-244).
Three residue deletions were chosen because they would be predicted to be least disruptive of a helical structure, if this region indeed adopts such a structure. In companion experiments, supernatants were taken from each sample after the 45 minute exposure to PMA or vehicle and assayed for the presence of GHBP ( Figure 5B ). However, the incomplete recovery of normal cleavage and shedding the 242-244AAA mutant as compared with rbGHR-∆242-244 suggests that the identity of these more membrane-proximal residues may also be of importance.
Processing and signaling properties of GHR cleavage region mutants.
The GHR is a glycoprotein that undergoes processing characteristic of surface glycoprotein receptors after synthesis in the endoplasmic reticulum in transit through the Golgi apparatus to the cell surface. Although it is uncertain where in the cell the metalloprotease-mediated GHR proteolysis and GHBP shedding occurs, several studies suggest that the receptor pool that includes mature (terminally glycosylated) GHRs is a target for proteolysis (12, 36, 37) . Given their resistance to proteolysis, we considered the possibility that rbGHR-∆237-239, rbGHR-∆240-242, and rbGHR-∆242-244 could be mutated in such a way as to be inappropriately routed within the cell, rendering them inaccessible to the cleaving apparatus. To examine this, we compared the glycosylation patterns of the mutants with that of the WT by testing the sensitivity of each to digestion with endoglycosidase H (endoH) (Figure 6 ). Sensitivity to deglycosylation by endoH suggests the presence of immature high-mannose forms of a glycoprotein which reside at a pre-trans-Golgi intracellular location rather than at the cell surface; in contrast, the acquisition of endoH resistance is characteristic of a glycoprotein with a mature pattern of carbohydrate chains that are added at a post-trans-Golgi location.
WT and mutant rbGHRs were transiently expressed in HEK-293 cells and immunoprecipitated from cell extracts with a monoclonal antibody directed at the GHR cytoplasmic domain (anti-GHR cyt-Mab ) (20) . Immunoprecipitates were treated with endoH or its vehicle control and eluates were resolved by SDS-PAGE and immunoblotted with anti-GHR cyt-AL47 .
As in unfractionated cell extracts in Figures 1 and 5 , the immunoprecipitated intact WT receptor was detected in two forms -a broad set of bands migrating at roughly 85-100 kD and a doublet at roughly 75 kD ( Figure 6 , lane 1). As we and others have previously observed for rbGHR in other cells and tissues (26, 38, 39) , endoH treatment caused the sharper bands to migrate more rapidly, but did not affect the migration of the broad 85-100 kD receptor form (lane 2 vs. 1). This pattern is highly consistent with that seen for the full-length rbGHR and indicates that the endoH-resistant broad set of bands constitutes the mature receptor and the sharper, endoH-sensitive bands are the immature (or precursor) forms. As seen in Figure 6 , lanes 3-6, the pattern of endoH susceptibility for rbGHR-∆237-239 and rbGHR-237-239AAA mimicked that of 
GHR proteolysis and desensitization of signaling.
In previous work, we demonstrated that treatment of serum-starved cells with PMA, PDGF, or serum rendered cells less responsive to GH for JAK2 activation and that this desensitization was prevented by the metalloprotease inhibitor, IC3 (12) . We receptor, a cytokine receptor family member (40) . We sought to use a cleavage-resistant GHR mutant to test further the underlying mechanism of PMA-induced desensitization of GH signaling in our system. As seen in Figure 8A , 
DISCUSSION
Metalloprotease-mediated proteolysis of the transmembrane GHR is likely to subserve several possible outcomes relevant for GH action. In those species that use this activity as a major mechanism of GHBP generation, the presence of the GHBP may affect GH action either locally or at a distant location, though this aspect of GHBP action
is as yet incompletely studied. Further, we have shown that in cells expressing either the endogenous GHR or a heterologous rbGHR, metalloprotease-mediated GHR proteolysis is detectable and can regulate cellular sensitivity to GH stimulation (12 and this study).
The current study extends our knowledge of the mechanisms and roles of regulated GHR proteolysis in several important ways. We used an adenoviral infection approach in HEK-293 cells to generate high levels of truncated GHR protein, allowing purification of GHR remnant and analysis by N-terminal sequencing of the cleavage site that resulted in the remnant. Although there are potential pitfalls with this approach, features of our analysis enhance our confidence that our results are relevant for understanding GHR proteolysis as it occurs in cells. In our initial experiments, we showed that both rbGHR del 297-406 (which was used later as the backbone for mutagenesis) and rbGHR 1-274-Myc-His (which was used for the purification) behaved in this system as we had previously observed for expression of full-length receptors and rbGHR del 297-406 in other cell types (11) (12) (13) . That is, despite infectious overexpression: 1) rbGHR del 297-406
and rbGHR 1-274-Myc-His underwent basal and PMA-induced cleavage and GHBP shedding with kinetics similar to what we previously showed; 2) PMA-induced proteolysis and GHBP shedding was inhibited by IC3; and 3) GH antagonized PMA's ability to cause receptor cleavage. In addition, rbGHR 1-274-Myc-His is analogous to a naturally-occurring alternatively-spliced GHR form that is known to effectively yield proteolytically-shed GHBP in other systems (31, 32) .
Our determination of the GHR cleavage site is the first such reported using these methods, to our knowledge. F 239 , the N-terminal residue present in the purified rabbit remnant, is eight residues N-terminal to the first predicted transmembrane amino acid (F 247 ) of the receptor. This is a region of the rbGHR that has very strong similarity to the human GHR (23 of the 25 residues in the proximal extracellular domain, including F 239 , are identical; see Figure 3B ). It is notable that to enable high level bacterial expression for crystallographic studies of the human GHBP, deVos, et al (33) possible that another secondary cleavage site(s) may also be utilized to some degree in GHBP generation.
Using our cleavage site sequence information, we studied the effects on rbGHR proteolysis and inducible GHBP shedding of introducing small internal deletion or alanine replacement mutations in and around the observed cleavage site. The most dramatic effect was seen with the rbGHR-∆237-239 mutant, in which three residues inclusive of the cleavage site were deleted. This mutant failed to undergo proteolysis or GHBP shedding. Yet, its glycosylation pattern suggested that it was routed normally in the biosynthetic pathway and it retained the ability to mediate JAK2 activation and undergo tyrosine phosphorylation in response to GH. In distinction, replacement of these three deleted amino acids with alanine residues (rbGHR-237-239-AAA) restored normal (or even supra-normal) proteolysis and inducible GHBP shedding. The findings with these two mutants strongly suggest that the presence of amino acids in this region, rather than the identity of those amino acids, is critical for receptor cleavage. Similar findings emerged from analysis of two other internal deletants, rbGHR-∆240-242 and rbGHR-∆242-244, in comparison to the AAA replacement versions of each (rbGHR-240-242-AAA and rbGHR-242-244-AAA). However, the inhibition of cleavage and shedding was not as complete with either of these two deletants as it was for rbGHR-∆237-239.
Furthermore, while the 240-242AAA mutant exhibited a substantially greater propensity to cleavage than the WT receptor, the 242-244AAA mutant was more resistant to cleavage. Collectively, these data suggest that the rbGHR cleaving machinery appears to recognize features in the proximal extracellular domain that relate to the length of the stem region and/or the distance from the plasma membrane to the receptor's first globular extracellular subdomain. Apparently, proper access for cleavage is not allowed if this distance is too small. This conclusion is supported by the recent work of Conte, et al (41) , who examined by mutagenesis the influence of the hGHR extracellular juxtamembrane region on inducible GHBP shedding. No cleavage site was mapped in that study, but deletion of residues 242-244 was seen as particularly deleterious to receptor shedding. Our rbGHR-∆242-244 was also relatively deficient in inducible (or basal) shedding. However, because our analysis also included a biochemical assessment of proteolysis (by detection of remnant), we observed that both rbGHR-∆242-244 and rbGHR-242-244AAA
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http://www.jbc.org/ Downloaded from generated a remnant pattern that differs slightly from that of the wild-type, rbGHR-237-239-AAA, or rbGHR-240-242-AAA (see Figure 5A ). Thus, in addition to quantitatively lessening cleavage, mutation of residues 242-244 may also change the preferred cleavage site utilized. We also note that mutation of the 242-244 region, while it did not abrogate JAK2 activation and receptor tyrosine phosphorylation, appeared to lessen the GHinducible component of activation in our system when compared to the WT or the other mutants. This suggests that this region may also be critical for aspects of GHR function other than regulation of proteolysis. This issue is worthy of further investigation.
We previously demonstrated that fibroblasts from a mouse with a homozygous disruption of the gene encoding Tumor Necrosis Factor-α Converting Enzyme (TACE/ADAM-17) failed to shed GHBP in response to PMA treatment and that TACE expression in these cells rescued inducible shedding (14) . This implicated TACE, a transmembrane member of the ADAM (A Disintegrin And Metalloprotease) subfamily of the adamalysin family of metalloproteases (15, 16) , as a GHBP sheddase. TACE has other transmembrane protein substrates, including TNF-α, transforming growth factor-α (TGF-α) and other EGF receptor ligands, TNF receptor-p75, L-selectin, interleukin-6 receptor, and amyloid precursor protein (35, 42, 43) . Features in ADAM substrates that allow their proteolysis are poorly understood. In substrates with known cleavage sites, no consensus emerges and cleavage determinants are not simple. The most consistent cleavage site feature among ADAM substrates is that they usually reside in a stalk region between the membrane and an initial globular extracellular subdomain (35) . Our findings for the rbGHR cleavage site fit well in this regard with the GHR being an ADAM substrate (34, 44) . Indeed, the crystal structure suggests that a short stem of roughly ten residues lies between the transmembrane domain and the beginning of extracellular subdomain 2, which contains the receptor dimerization domain (33) .
We exploited the inability of rbGHR-∆237-239 to undergo cleavage to further examine the relationship between inducible receptor proteolysis and cellular sensitivity to GH. We previously demonstrated such a link in that in several model systems pretreatment with stimuli that induce GHR cleavage lessened the JAK2 activation in response to acute exposure to GH and this desensitization was blocked by inclusion of the metalloprotease inhibitor IC3 during the preincubation (11). In the current study, we found that PMA pretreatment led to desensitization to GH in cells that expressed either WT or rbGHR-237-239-AAA (both cleavable receptors), but not in those that expressed rbGHR-∆237-239, the non-cleavable receptor. This complements our previous observations gleaned with the metalloprotease inhibitor and strongly implicates metalloprotease-mediated proteolysis as one mechanism of desensitization of GH Note that GH inhibits PMA-induced proteolysis in this system. 
